Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.
Also called NCT05526703
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 108 participants
- Registry
-
NCT05526703
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT05526703. Randomized; double masking; primary purpose treatment. Start 2022-09-28 (actual); primary completion 2023-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
- Condition
- Essential Hypertension
- Intervention (Drug)
- D064, D701, placebo of D012
- Intervention (Drug)
- D012, placebo of D064, placebo of D701
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct05526703- Content hash
287d26c0827a53eaa2d0ddf861178a478681c8308856f2baa6073c58faa54869